Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.38 |
| ▸ | RAB9A | P51151 | 7/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 6/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30167903 | 1.00 | ALDH1A1 (0.38) | ALDH1A1RAB9AMAPTHTTNPC1 | |
| SCHEMBL18035433 | 0.82 | MDM4 (0.44) | ALDH1A1RAB9AMAPTHTT | |
| SCHEMBL131814 | 0.82 | GAA (0.45) | ALDH1A1RAB9AMAPTHTTNPC1 | |
| SCHEMBL8346131 | 0.82 | NPC1 (0.50) | ALDH1A1RAB9AMAPTHTTNPC1 | |
| SCHEMBL30393394 | 0.82 | GAA (0.45) | ALDH1A1RAB9AMAPTHTTNPC1 | |
| SCHEMBL3842734 | 0.78 | KDM4E (0.52) | ALDH1A1RAB9AMAPTNPC1MEN1 | |
| SCHEMBL3052363 | 0.78 | GRIN2D (0.46) | ALDH1A1MAPTHTTMEN1KMT2A | |
| SCHEMBL4363328 | 0.77 | ALDH1A1 (0.57) | ALDH1A1RAB9AMAPTNPC1MEN1 | |
| SCHEMBL9576920 | 0.75 | HTT (0.42) | ALDH1A1RAB9AMAPTHTTMEN1 | |
| SCHEMBL28535884 | 0.72 | KMT2A (0.56) | ALDH1A1RAB9AMAPTNPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5194614-A | — | — | None | — | — | JP | disclosed |
| WO-2025084057-A1 | METHOD FOR PRODUCING MONOMER PRECURSOR COMPOSITION | 東レ株式会社 | 2025-04-24 | — | — | WO | disclosed |
| WO-2024214816-A1 | PHOTOSENSITIVE RESIN LAMINATE AND METHOD FOR FORMING RESIST PATTERN | 旭化成株式会社 | 2024-10-17 | — | — | WO | disclosed |
| US-11155703-B2 | Curable composition, manufacturing method of curable composition, cured film, manufacturing method of cured film, color filter, solid-state imaging element, solid-state imaging device, and infrared sensor | FUJIFILM CORPORATION (JP) | 2021-10-26 | — | — | US | disclosed |
| EP-3505545-B1 | CURABLE COMPOSITION AND PRODUCTION PROCESS THEREFOR, CURED FILM AND PRODUCTION PROCESS THEREFOR, COLOR FILTER, SOLID-STATE IMAGING ELEMENT, SOLID-STATE IMAGING DEVICE, AND INFRARED SENSOR | FUJIFILM CORP (JP) | 2021-05-26 | — | — | EP | disclosed |
| US-11015007-B2 | Active energy ray-curable composition and cured product thereof | SHOWA DENKO K.K. (JP) | 2021-05-25 | — | — | US | disclosed |
| EP-3428198-B1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION AND CURED PRODUCT THEREOF | SHOWA DENKO KK (JP) | 2020-11-25 | — | — | EP | disclosed |
| EP-3505545-A1 | CURABLE COMPOSITION AND PRODUCTION PROCESS THEREFOR, CURED FILM AND PRODUCTION PROCESS THEREFOR, COLOR FILTER, SOLID-STATE IMAGING ELEMENT, SOLID-STATE IMAGING DEVICE, AND INFRARED SENSOR | FUJIFILM Corporation (JP) | 2019-07-03 | — | — | EP | disclosed |
| US-20190185656-A1 | CURABLE COMPOSITION, MANUFACTURING METHOD OF CURABLE COMPOSITION, CURED FILM, MANUFACTURING METHOD OF CURED FILM, COLOR FILTER, SOLID-STATE IMAGING ELEMENT, SOLID-STATE IMAGING DEVICE, AND INFRARED SENSOR | FUJIFILM CORPORATION (JP) | 2019-06-20 | — | — | US | disclosed |
| US-20190040175-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION AND CURED PRODUCT THEREOF | SHOWA DENKO K.K. (JP) | 2019-02-07 | — | — | US | disclosed |
| WO-2006097460-A1 | HYDROXAMATES AS HISTONE DEACETYLASE INHIBITORS AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM | MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. (LU) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006097449-A1 | N-HYDROXYAMIDES OMEGA-SUBSTITUTED WITH TRICYCLIC GROUPS AS HISTONE DEACETYLASE INHIBITORS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS | MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. (LU) | 2006-09-21 | — | — | WO | disclosed |
| US-6875888-B2 | Method for the production of esters of unsaturated carboxylic acids | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-05 | — | — | US | disclosed |
| US-20030139599-A1 | Method for the production of esters of unsaturated carboxylic acids | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-24 | — | — | US | disclosed |
| JP-H05194614-A | COMPOSITION FOR INHIBITING ADDITION POLYMERIZATION OF ACRYLIC ACID AND ESTER THEREOF | UNIROYAL CHEM CO INC | 1993-08-03 | — | — | JP | disclosed |
| US-4316021-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1982-02-16 | — | — | US | disclosed |
| US-4243813-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1981-01-06 | — | — | US | disclosed |
| US-4196125-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1980-04-01 | — | — | US | disclosed |
| US-4118573-A | ANTIVIRAL AGENTS | ELI LILLY AND COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-4018790-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139599-A1 | Method for the production of esters of unsaturated carboxylic acids | CBR3, ADH1C, CBR1 | ALDH1A1 119/4885RAB9A 4456/4885MAPT 4623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.